Journal
JOURNAL OF DIGESTIVE DISEASES
Volume 13, Issue 10, Pages 525-535Publisher
WILEY
DOI: 10.1111/j.1751-2980.2012.00627.x
Keywords
carnitine O-palmitoyltransferase; fatty acids; Ginkgo biloba; non-alcoholic fatty liver disease
Categories
Funding
- National Natural Science Foundation of China [81070323]
- National Science and Technology Major Projects of China [2009ZX10004-601]
- Development Projects of Science and Technology Commission of Shanghai [03DZ19551, 06DZ19727]
- Leading Academic Discipline Project of Shanghai Municipal Education Commission [J50301]
Ask authors/readers for more resources
Objective To investigate the potential effect of Ginkgo biloba extract (GBE) on the prevention and treatment of nonalcoholic fatty liver disease (NAFLD). Methods Male Wistar rats were divided into 4 groups (the control group, GBE group, high-fat diet [HFD] group and HFD?+?GBE group). The human hepatocellular carcinoma cell line (HepG2) was treated with GBE and its flavonoid ingredients. The fatty acid composition of the rat liver was analyzed with gas chromatography/time-of-flight mass spectrometry (GC/TOFMS). Triglyceride contents of both the rat liver and HepG2 cells were measured by enzymatic colorimetric method. The expressions of fatty acid metabolism-related genes were analyzed with real-time reverse transcription-polymerase chain reaction (RT-PCR). The protein expression and enzymatic activity were subsequently measured. Results In rat livers, GBE reduced the elevations of hepatic triglyceride contents caused by HFD and the increased hepatic fatty acids were differentially affected by GBE. Notably, the expression and total activity of the fatty acid beta-oxidation rate-limiting enzyme, carnitine palmitoyltransferase 1a (CPT1A), were also promoted with GBE ingestion. In HepG2 cells, GBE and its ingredients, quercetin, kaempferol and isorhamnetin, could decrease the cellular triglyceride content and upregulate the expression and total activity of CPT1A, respectively. Conclusions The triglyceride-lowering effect of GBE on the HFD rat liver is closely associated with the increased expression and activity of CPT1A, and the flavonoid ingredients are the major contributors of GBE.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available